Trials / Conditions / Myelogenous Leukemia, Chronic

Myelogenous Leukemia, Chronic

6 registered clinical trials studyying Myelogenous Leukemia, Chronic.

Status	Trial	Sponsor	Phase
Unknown	A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous L NCT01503502	Jiangsu HengRui Medicine Co., Ltd.	Phase 2
Completed	A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive ( NCT00471497	Novartis Pharmaceuticals	Phase 3
Completed	MK0457 in Patients With Leukemia (0457-003) NCT00111683	Merck Sharp & Dohme LLC	Phase 1
Completed	Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia ( NCT02736721	Hoffmann-La Roche	Phase 3
Completed	Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML) NCT00038597	M.D. Anderson Cancer Center	Phase 2
Completed	Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) NCT00179764	Ann & Robert H Lurie Children's Hospital of Chicago	N/A